Rockwell Labs Ltd and ConidioTec LLC are excited to announce the acquisition by Rockwell of the patented Aprehend biopesticide for bed bugs and associated spray application products.
“Aprehend is a perfect complement to our product line with its one-of-a-kind mode of action,” said Dr. Cisse Spragins, Founder and CEO of Rockwell. “I’ve admired the product from afar for some time, and the excellent job Dr. Nina Jenkins (Founder and CTO of ConidioTec), and her team have done developing the product formulation, application technology and treatment protocol, and launching it into the market. The Aprehend team has been great to work with through this process, with their commitment to a successful transition. I’m pleased that Drs. Jenkins and Bellicanta will continue to support the product and its industry users through the transition period to ensure we maintain the high standards they have set for both technical training and production operations.”
“We are delighted to see Aprehend join the incredible product portfolio at Rockwell Labs” said Dr. Nina Jenkins. “It was our aim right from the beginning to find the right partner for Aprehend, to ensure its expansion and continued success in the industry. Rockwell is the perfect home for Aprehend, where it joins our other favorite bed bug product CimeXa®. Rockwell now offers the optimal one-two punch for the control and prevention of bed bugs. I am excited to continue in my role of technical support for industry users, and look forward to seeing everyone at PestWorld, Orlando in October.”
With immediate effect, operations and order fulfillment will shift to Rockwell. Distributor partners and prior ConidioTec direct customers will receive instructions by email for ordering. Please reach out to Rockwell at with any questions. Listen for the new extension numbers to reach the relevant team member on 800-891-8610. For questions regarding orders placed with ConidioTec prior to August 1 and associated account